Speciality: Oncology
Description:
Welcome to this insightful discussion featuring Dr. Vamshi Krishna M, a renowned expert in oncology, as he delves into the unmet needs and challenges in the current care of ALK-positive Non-Small Cell Lung Cancer (NSCLC). In this video, Dr. Vamshi highlights the significant gaps in treatment options, including resistance mechanisms, limited access to next-generation therapies, and the need for personalized approaches to improve patient outcomes. He emphasizes the importance of early detection, advanced diagnostics, and the development of novel therapeutic strategies to address these pressing issues.
Dr. Vamshi further explores the real-world challenges faced by clinicians managing ALK-positive NSCLC, such as treatment sequencing, managing side effects, and optimizing therapy for better survival rates. He discusses the evolving landscape of targeted therapies and immunotherapy while underscoring the necessity for more clinical trials and collaborative research to bridge existing gaps. His expertise provides valuable perspectives for oncologists, researchers, and healthcare professionals striving to enhance patient care in this niche yet critical area of lung cancer.
Don’t miss this compelling discussion that sheds light on the future directions and unmet needs in ALK-positive NSCLC. Stay tuned for more expert insights from Dr. Vamshi Krishna M and other leading voices in oncology. Be sure to watch till the end and subscribe for updates on upcoming videos that continue to explore groundbreaking advancements in cancer care.
See More Webinars @ Hidoc Webinars
1.
Global warming could be driving up women's cancer risk, find researchers
2.
Mezigdomide Combinations Show Promise in Multiple Myeloma
3.
Tafasitamab Regimen Improves PFS in Relapsed/Refractory Follicular Lymphoma
4.
In patients with prostate cancer, second-generation antiandrogens may worsen fatigue, falls, and cognitive decline.
5.
No increased risk of childhood cancer near UK nuclear sites, study finds
1.
Uncovering the Reality of Colon Cancer: A Look at Real Images
2.
Feline Anemia: Diagnosis and Treatment with Focus on Rasburicase Complications
3.
Case Study: Diagnostic and Therapeutic Challenges in Aplastic Anemia Mimicking Hypoplastic Myelodysplastic Syndrome
4.
Bone-on-a-Chip Systems: A Revolutionary Approach to Modeling Hematological Cancers
5.
Cardio-Oncology in Survivors: Safeguarding Hearts Through Multidisciplinary Care
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part III
2.
Unmet Needs in ALK Positive NSCLC- The Challenges in the Current Care
3.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VI
4.
From Relapse to Remission: Mapping the Treatment Journey in Adult R/R-Cell ALL - Part 2
5.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part III
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation